{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:38:28Z","timestamp":1769207908397,"version":"3.49.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jocd.2017.10.041","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:16:53Z","timestamp":1511223413000},"page":"3-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis"],"prefix":"10.1016","volume":"21","author":[{"given":"E. Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Dell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rosenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2017.10.041_bib0010","first-page":"825","article-title":"Proceedings of the Santa Fe Bone Symposium 2006","volume":"2","author":"Lewiecki","year":"2006","journal-title":"Womens Health"},{"key":"10.1016\/j.jocd.2017.10.041_bib0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jocd.2007.12.017","article-title":"Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3\u20134, 2007","volume":"11","author":"Lewiecki","year":"2008","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jocd.2009.02.002","article-title":"2008 Santa Fe Bone Symposium: update on osteoporosis","volume":"12","author":"Lewiecki","year":"2009","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2009.12.003","article-title":"2009 Santa Fe Bone Symposium","volume":"13","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2010.12.001","article-title":"Osteoporosis update from the 2010 Santa Fe Bone Symposium","volume":"14","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2011.11.004","article-title":"Proceedings of the 2011 Santa Fe Bone Symposium","volume":"15","author":"Lewiecki","year":"2012","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jocd.2013.01.001","article-title":"Osteoporosis update from the 2012 Santa Fe Bone Symposium","volume":"16","author":"Lewiecki","year":"2013","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jocd.2013.11.006","article-title":"Osteoporosis update: proceedings of the 2013 Santa Fe Bone Symposium","volume":"17","author":"Lewiecki","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/07435800.2015.1005746","article-title":"Update on osteoporosis from the 2014 Santa Fe Bone Symposium","volume":"40","author":"Lewiecki","year":"2015","journal-title":"Endocr Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocd.2015.11.003","article-title":"Proceedings of the 2015 Santa Fe Bone Symposium: clinical applications of scientific advances in osteoporosis and metabolic bone disease","volume":"19","author":"Lewiecki","year":"2016","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jocd.2017.01.001","article-title":"Proceedings of the 2016 Santa Fe Bone Symposium: new concepts in the management of osteoporosis and metabolic bone diseases","volume":"20","author":"Lewiecki","year":"2017","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0065","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0070","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0075","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0080","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0085","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0090","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0095","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0100","author":"Lewiecki"},{"key":"10.1016\/j.jocd.2017.10.041_bib0105","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","article-title":"Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop","volume":"99","author":"Silverberg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0110","series-title":"The Parathyroids","first-page":"331","article-title":"Normocalcemic PHPT","author":"Cusano","year":"2015"},{"key":"10.1016\/j.jocd.2017.10.041_bib0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0120","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0125","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0130","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/jbmr.98","article-title":"Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT","volume":"25","author":"Hansen","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0135","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/jbmr.1841","article-title":"Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women","volume":"28","author":"Stein","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0140","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2012-4255","article-title":"Trabecular bone score (TBS)\u2014a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism","volume":"98","author":"Silva","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bone.2012.11.041","article-title":"\u201cTrabecular Bone Score\u201d (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism","volume":"53","author":"Romagnoli","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.10.041_bib0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-13-0305","article-title":"Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0155","series-title":"The Parathyroids","first-page":"489","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism","author":"Bilezikian","year":"2015"},{"key":"10.1016\/j.jocd.2017.10.041_bib0160","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/endo.138.11.5505","article-title":"The effects of programmed administration of human parathyroid hormone fragment (1\u201334) on bone histomorphometry and serum chemistry in rats","volume":"138","author":"Dobnig","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.jocd.2017.10.041_bib0165","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0170","first-page":"41","article-title":"Parathyroid hormone as an anabolic therapy for women and men","volume":"28","author":"Bilezikian","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2017.10.041_bib0175","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.10.041_bib0180","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0185","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0195","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2014-2267","article-title":"PTH(1\u201384) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy","volume":"99","author":"Cusano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0200","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1210\/jc.2015-4135","article-title":"Therapy of hypoparathyroidism with PTH(1\u201384): a prospective six year investigation of efficacy and safety","volume":"101","author":"Rubin","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0205","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0210","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0215","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1210\/jc.2016-2530","article-title":"PTH(1\u201334) for the primary prevention of postthyroidectomy hypocalcemia: the THYPOS trial","volume":"101","author":"Palermo","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0220","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00198-016-3513-y","article-title":"Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group","volume":"27","author":"Silverman","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0225","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1359\/jbmr.090731","article-title":"Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures","volume":"25","author":"Aspenberg","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0230","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2106\/JBJS.J.01379","article-title":"Parathyroid hormone 1\u201384 accelerates fracture-healing in pubic bones of elderly osteoporotic women","volume":"93","author":"Peichl","year":"2011","journal-title":"J Bone Joint Surg Am"},{"issue":"862","key":"10.1016\/j.jocd.2017.10.041_bib0235","first-page":"e861","article-title":"Western osteoporosis alliance clinical practice series: evaluating the balance of benefits and risks of long-term osteoporosis therapies","volume":"130","author":"Hanley","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0240","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jocd.2013.09.018","article-title":"Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosis","volume":"17","author":"Lewiecki","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11914-017-0376-x","article-title":"Using osteoporosis therapies in combination","volume":"15","author":"McClung","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jocd.2017.10.041_bib0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","article-title":"Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday","volume":"126","author":"McClung","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0255","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0260","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.10.041_bib0265","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0270","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jbmr.2442","article-title":"The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"30","author":"Black","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0275","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0280","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00198-015-3179-x","article-title":"Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years","volume":"26","author":"Ferrari","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0285","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0290","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","article-title":"Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates","volume":"101","author":"Miller","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0295","first-page":"S49","article-title":"Hip BMD by DXA can reliably estimate reduction in hip risk in osteoporosis trials: a meta-regression","volume":"30","author":"Black","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0300","first-page":"S49","article-title":"Relationship between total hip BMD T-score and incidence of nonvertebral fracture with up to 8 years of denosumab treatment","volume":"30","author":"Ferrari","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0305","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jbmr.1854","article-title":"Goal-directed treatment of osteoporosis","volume":"28","author":"Cummings","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0310","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0315","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0320","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.GME.0000123641.76105.B5","article-title":"Changes in bone density and turnover after alendronate or estrogen withdrawal","volume":"11","author":"Wasnich","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.jocd.2017.10.041_bib0325","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0330","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.10.041_bib0335","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3110","article-title":"Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases","volume":"32","author":"Anastasilakis","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0340","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archinte.163.7.789","article-title":"Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial","volume":"163","author":"Ascott-Evans","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0345","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","article-title":"Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women","volume":"23","author":"Freemantle","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0350","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis\u2014where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0360","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","article-title":"Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial","volume":"25","author":"Schwartz","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0365","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00198-016-3553-3","article-title":"Cancel the denosumab holiday","volume":"27","author":"McClung","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0370","author":"Amgen"},{"key":"10.1016\/j.jocd.2017.10.041_bib0375","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2007-0711","article-title":"Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis","volume":"93","author":"Boonen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0380","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2017.10.041_bib0385","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jbmr.3051","article-title":"Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis","volume":"32","author":"Cosman","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0390","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jbmr.2991","article-title":"Effects of abaloparatide-SC on fractures and bone mineral density in subgroups of postmenopausal women with osteoporosis and varying baseline risk factors","volume":"32","author":"Cosman","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0395","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0400","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0889-857X(03)00061-9","article-title":"Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis?","volume":"29","author":"Burr","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jocd.2017.10.041_bib0405","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1469-7580.2009.01186.x","article-title":"The anatomical basis for a novel classification of osteoarthritis and allied disorders","volume":"216","author":"McGonagle","year":"2010","journal-title":"J Anat"},{"key":"10.1016\/j.jocd.2017.10.041_bib0410","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.58.1.20","article-title":"Bone scintigraphy in chronic knee pain: comparison with magnetic resonance imaging","volume":"58","author":"Boegard","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocd.2017.10.041_bib0415","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00008","article-title":"Bone marrow edema and its relation to progression of knee osteoarthritis","volume":"139","author":"Felson","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072714","article-title":"Are bisphosphonates effective in the treatment of osteoarthritis pain? A meta-analysis and systematic review","volume":"8","author":"Davis","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocd.2017.10.041_bib0425","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2012-202231","article-title":"Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial","volume":"72","author":"Reginster","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocd.2017.10.041_bib0430","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.joca.2007.06.011","article-title":"Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials","volume":"16","author":"Bruyere","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jocd.2017.10.041_bib0435","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/art.22728","article-title":"Glucosamine for pain in osteoarthritis: why do trial results differ?","volume":"56","author":"Vlad","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jocd.2017.10.041_bib0440","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.jocd.2017.10.041_bib0445","article-title":"Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: a network meta-analysis","author":"Hazlewood","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jocd.2017.10.041_bib0450","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","article-title":"Generalised bone loss in patients with early rheumatoid arthritis","volume":"344","author":"Gough","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2017.10.041_bib0455","first-page":"S77","article-title":"Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study","volume":"24","author":"Allaart","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0460","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.10135","article-title":"Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis","volume":"46","author":"Mottonen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jocd.2017.10.041_bib0465","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group","volume":"333","author":"Kirwan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0470","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0475","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative dosing","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jocd.2017.10.041_bib0480","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199605163342002","article-title":"Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications","volume":"334","author":"O'Dell","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0485","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus placebo or adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0490","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1505467","article-title":"A randomized, controlled trial of total knee replacement","volume":"373","author":"Skou","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0495","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/jamasurg.2015.5085","article-title":"Association of frailty and 1-year postoperative mortality following major elective noncardiac surgery: a population-based cohort study","volume":"151","author":"McIsaac","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jocd.2017.10.041_bib0500","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"van Staa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jocd.2017.10.041_bib0505","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/ard.2008.100503","article-title":"Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study","volume":"68","author":"Vosse","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocd.2017.10.041_bib0510","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3899\/jrheum.101196","article-title":"Arthritis increases the risk for fractures\u2014results from the Women's Health Initiative","volume":"38","author":"Wright","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0515","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3899\/jrheum.100363","article-title":"Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases\u2014a case-control study with 53,108 patients with fracture","volume":"37","author":"Weiss","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0520","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMra040226","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"350","author":"O'Dell","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0525","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00198-015-3476-4","article-title":"Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis","volume":"27","author":"Amiche","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0530","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jocd.2017.10.041_bib0535","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3949\/ccjm.75a.08014","article-title":"Bisphosphonates and osteonecrosis of the jaw: innocent association or significant risk?","volume":"75","author":"Carey","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0540","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpeds.2016.09.056","article-title":"The determinants of peak bone mass","volume":"180","author":"Gordon","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jocd.2017.10.041_bib0545","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0550","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF01880413","article-title":"The contribution of bone loss to postmenopausal osteoporosis","volume":"1","author":"Hui","year":"1990","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0555","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0560","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1210\/jcem.85.3.6451","article-title":"Influence of puberty on muscle area and cortical bone area of the forearm in boys and girls","volume":"85","author":"Schoenau","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0565","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-3476(03)00187-2","article-title":"Importance of lean mass in the interpretation of total body densitometry in children and adolescents","volume":"143","author":"Hogler","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jocd.2017.10.041_bib0570","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bone.2004.06.009","article-title":"The relationship between lean body mass and bone mineral content in paediatric health and disease","volume":"35","author":"Crabtree","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.10.041_bib0575","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00198-006-0183-1","article-title":"Idiopathic juvenile osteoporosis\u2014an analysis of the muscle-bone relationship","volume":"17","author":"Pludowski","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0580","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"2013 Pediatric position development conference: executive summary and reflections","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0585","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/jbmr.392","article-title":"Hutchinson-Gilford progeria is a skeletal dysplasia","volume":"26","author":"Gordon","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0595","series-title":"Kaiser SCAL Healthy Bones Program","author":"Dell","year":"2017"},{"key":"10.1016\/j.jocd.2017.10.041_bib0600","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMc1612804","article-title":"GGPS1 mutation and atypical femoral fractures with bisphosphonates","volume":"376","author":"Roca-Ayats","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0605","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/BOT.0b013e3181b6499b","article-title":"Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?","volume":"24","author":"Koh","year":"2010","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.jocd.2017.10.041_bib0610","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/SPC.0b013e3283552d7d","article-title":"Atypical femoral fractures: epidemiology, etiology, and patient management","volume":"6","author":"Donnelly","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.jocd.2017.10.041_bib0615","series-title":"Stopping bisphosphonate treatment decreases the risk of having a second atypical femoral fracture","author":"Dell","year":"2012"},{"key":"10.1016\/j.jocd.2017.10.041_bib0620","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","article-title":"Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study","volume":"34","author":"Schuit","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.10.041_bib0625","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(91)90512-V","article-title":"Prophylaxis and treatment of osteoporosis","volume":"90","author":"Conference","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0630","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","article-title":"Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score","volume":"18","author":"Silva","year":"2015","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.10.041_bib0635","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/14656566.2016.1124856","article-title":"Management of severe osteoporosis","volume":"17","author":"Miller","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jocd.2017.10.041_bib0640","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11914-013-0161-4","article-title":"Evaluation and management of the premenopausal woman with low BMD","volume":"11","author":"Cohen","year":"2013","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jocd.2017.10.041_bib0645","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","article-title":"Hypophosphatasia: an overview for 2017","volume":"102","author":"Whyte","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.10.041_bib0650","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2006-1902","article-title":"Adult hypophosphatasia treated with teriparatide","volume":"92","author":"Whyte","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0655","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/j.ajkd.2015.01.025","article-title":"Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report","volume":"65","author":"Palcu","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jocd.2017.10.041_bib0660","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1056\/NEJMcp1513724","article-title":"Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0665","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jbmr.3030","article-title":"Risk and prevention of fracture in patients with major medical illnesses: a mini-review","volume":"31","author":"Cummings","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0670","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/jbmr.1698","article-title":"Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention","volume":"27","author":"Eisman","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0675","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2015-3156","article-title":"Underdiagnosis and undertreatment of osteoporosis: the battle to be won","volume":"101","author":"Miller","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0680","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrd3977","article-title":"The most transformative drugs of the past 25 years: a survey of physicians","volume":"12","author":"Kesselheim","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jocd.2017.10.041_bib0685","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A crisis in the treatment of osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0690","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.10.041_bib0695","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.2565","article-title":"Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996\u20132012: an ecological analysis","volume":"30","author":"Jha","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0700","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0705","author":"National Institutes of Health"},{"key":"10.1016\/j.jocd.2017.10.041_bib0710","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.maturitas.2014.07.005","article-title":"The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"79","author":"Rizzoli","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.jocd.2017.10.041_bib0715","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJM199406233302502","article-title":"Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate","volume":"330","author":"Sebastian","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0720","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/oxfordjournals.aje.a115709","article-title":"Caffeine and the risk of hip fracture: the Framingham Study","volume":"132","author":"Kiel","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0725","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01623310","article-title":"Caffeine and the calcium economy revisited","volume":"5","author":"Barger-Lux","year":"1995","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.10.041_bib0730","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jama.1994.03510280042030","article-title":"Coffee-associated osteoporosis offset by daily milk consumption: the Rancho Bernardo study","volume":"271","author":"Barrett-Connor","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.10.041_bib0735","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.gme.0000222475.93345.b3","article-title":"Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society","volume":"13","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.jocd.2017.10.041_bib0740","author":"US Food & Drug Administration"},{"key":"10.1016\/j.jocd.2017.10.041_bib0745","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.metabol.2017.01.032","article-title":"Vitamin K and osteoporosis: myth or reality?","volume":"70","author":"Palermo","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.jocd.2017.10.041_bib0750","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/nu5083022","article-title":"Magnesium and osteoporosis: current state of knowledge and future research directions","volume":"5","author":"Castiglioni","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jocd.2017.10.041_bib0755","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3945\/ajcn.113.067488","article-title":"Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study","volume":"99","author":"Orchard","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jocd.2017.10.041_bib0760","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005326.pub2","article-title":"Strontium ranelate for preventing and treating postmenopausal osteoporosis","author":"O'Donnell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jocd.2017.10.041_bib0765","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1096\/fasebj.1.5.3678698","article-title":"Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women","volume":"1","author":"Nielsen","year":"1987","journal-title":"FASEB J"},{"key":"10.1016\/j.jocd.2017.10.041_bib0770","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jtemb.2009.03.003","article-title":"Boron and fish oil have different beneficial effects on strength and trabecular microarchitecture of bone","volume":"23","author":"Nielsen","year":"2009","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.jocd.2017.10.041_bib0775","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1515\/cclm-2012-0868","article-title":"Trace elements and bone health","volume":"51","author":"Zofkova","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jocd.2017.10.041_bib0780","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jbmr.2202","article-title":"Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011","volume":"29","author":"Solomon","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.10.041_bib0785","author":"American Society for Bone and Mineral Research"},{"key":"10.1016\/j.jocd.2017.10.041_bib0790","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/whe.15.97","article-title":"Bone health ECHO: telementoring to improve osteoporosis care","volume":"12","author":"Lewiecki","year":"2016","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1016\/j.jocd.2017.10.041_bib0795","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00198-016-3708-2","article-title":"Telementoring: a novel approach to reducing the osteoporosis treatment gap","volume":"28","author":"Lewiecki","year":"2017","journal-title":"Osteoporos Int"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695017302470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695017302470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:41:19Z","timestamp":1761082879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695017302470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1094695017302470"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2017.10.041","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of Osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2017.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The International Society for Clinical Densitometry.","name":"copyright","label":"Copyright"}]}}